ARCHIVES

Gleevec For KIT-positive Tumors Shows 92 Percent Overall Survival

This article is from The Cancer Letter archive.

Vol. 34 No. 7 | July 29, 2011

Download PDF Visit The Full Archive

Related Articles

Cyclamate Review Committee Starts Survey; Inventor Castigates NCI

September 12, 1975

In Their Own Words: “Blessed with The Opportunity” vs. “LOWEST Morale Ever”

May 23, 2014

GAO Offers Two Suggestions For Plant Screening

April 4, 1980

Breast Cancer action Plan Calls For More federal Coordination, Patient Participation

March 23, 1994

Smoking Cessation Training Follows Doctors Into Practice

October 29, 2004

In Brief : Three Named To Leadership Posts At St. Jude; Mitchell Weiss Appointed Chair of Hematology

July 11, 2014